Pharmaceutical Naming Regulation - Understanding the Latest Developments
Apr 06 '21 | 01:00 PM (EST)
Online Event
Event Information
The FDA’s recently released naming guidance has several key additions and changes you must understand when developing names. Failure to follow the guidelines could create confusion and lead to medication errors.
No one test or standard is adequate to determine whether a proposed name might contribute to medication errors. The FDA advocates the use of a combination of different, complementary tests to identify and remedy potential sound-alike and look-alike confusion with existing drug names.
Key Webinar Takeaways:
How the prescreening process relates to attributes that may contribute to medication errors in naming drugs
Suggested methods of evaluating the risk of medication errors related to naming
The FDA process for notifying applicants that have similar names in the FDA queue.
EVENT HAS ENDED
Don’t worry, you can explore
other similar events
EVENT HAS ENDED
VIEW SIMILAR EVENTS
Have a question?
Send your queries to the event organizer
CONTACT ORGANIZER
Host Virtual Events with
Townhall Learn More
Townhall Learn More